journal
MENU ▼
Read by QxMD icon Read
search

Surgical Oncology Clinics of North America

journal
https://www.readbyqxmd.com/read/30213418/measuring-quality-in-a-shifting-payment-landscape-implications-for-surgical-oncology
#1
EDITORIAL
Daniel E Abbott, Caprice C Greenberg
No abstract text is available yet for this article.
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213417/quality-in-a-shifting-payment-landscape-and-the-implications-for-surgical-oncology
#2
EDITORIAL
Timothy M Pawlik
No abstract text is available yet for this article.
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213416/expanding-the-scope-of-evidence-based-cancer-care
#3
REVIEW
Victoria Rendell, Ryan Schmocker, Daniel E Abbott
This article explores how oncology research can be expanded to ensure that research spending results in maximum benefit. The focus has shifted to the value and quality of care, which view cancer care with the perspective of the patient at the center and cover the spectrum of care. Because there is no agreed-upon definition for value in cancer care, we overview various contributions to defining value and quality in oncology. We outline how cancer care costs are measured in the United States and explore outcome measures that have been proposed and implemented to enable us to assess value in oncology...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213415/the-accountable-care-organization-for-surgical-care
#4
REVIEW
Matthew J Resnick
Rising health care costs superimposed on uncertainty surrounding the relationship between health care spending and quality have resulted in an urgent need to develop strategies to better align health care payment with value. Such approaches, at least in theory, work to achieve the dual aims of reducing growth in health care spending and improving population health. To date, surgery has not been prioritized in accountable care organizations (ACOs). Nonetheless, it is critically important to begin to consider strategic and impactful mechanisms through which surgery can be seamlessly woven into innovative population health models...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213414/malignant-bowel-obstruction-reappraising-the-value-of-surgery
#5
REVIEW
Robert E Roses, Ian W Folkert, Robert S Krouse
Urgent palliative surgery in the setting of advanced malignancy is associated with significant morbidity, mortality, and cost. Malignant bowel obstruction is the most frequent indication for such intervention. Traditional surgical dogma is often invoked to justify associated risks and cost, but little evidence exists to support surgical over nonsurgical approaches. Evolving evidence may provide more meaningful guidance for treatment selection.
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213413/regionalization-and-its-alternatives
#6
REVIEW
Stephanie Lumpkin, Karyn Stitzenberg
This article begins by introducing the historical background surrounding the volume-outcomes relationship literature, particularly in complex cancer surgery. The state of evidence surrounding mortality, as well as other outcomes, in relation to both hospital and surgeon procedure volume is synthesized. Where it is understood, the level of adoption of regionalization of various complex surgeries in the United States is also presented. Various controversies are weighed and discussed. Finally, various models of regionalization and proposed alternatives to regionalization from the peer-reviewed literature are presented...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213412/health-related-quality-of-life-the-impact-on-morbidity-and-mortality
#7
REVIEW
Andrea Sitlinger, Syed Yousuf Zafar
In the age of ever-expanding treatments and precision medicine, the hope for cure remains the ultimate goal for patients and providers. Equally important to many patients is the quality of life achieved during and after treatment. Evidence suggests that overall quality of life is important to patients and plays a role in determining outcomes in patients with cancer. This article examines components of health-related quality of life and cancer treatment, including physical, psychosocial, and financial burden, as well as how these components affect patients' overall wellbeing and survival...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213411/engaging-stakeholders-and-patient-partners
#8
REVIEW
Kathryn E Hacker, Angela B Smith
Recent advances in engagement of stakeholders and patient partners in clinical research have bridged the disconnect between researchers and stakeholders, resulting in improved research goals with relevant outcomes, increased clinical trial enrollment, and improved communication of research results. This article focuses on the mechanisms, challenges, and benefits of patient and stakeholder engagement, with strategies for improvement. The 3 stages of clinical research and key iterative steps to create a reciprocal relationship are presented...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213410/cancer-care-delivery-research-a-path-to-improving-the-quality-of-oncologic-surgical-care
#9
REVIEW
Trista J Stankowski-Drengler, Heather B Neuman
The goal of cancer care delivery research (CCDR) is to inform sustainable practice changes that will provide better clinical outcomes and patient experience guided by patient values. CCDR encompasses salient concepts from other well-established research approaches and spans the continuum of research from hypothesis generation to effectiveness studies to policy development. CCDR incorporates pertinent attributes, such as saliency to stakeholders, inclusion of diverse participants, and implementation into real-world settings...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213409/utilizing-big-data-in-cancer-care
#10
REVIEW
Cary Jo R Schlick, Joshua P Castle, David J Bentrem
Clinical research has boomed over the past decade, with the development of multiple clinical datasets that are available for retrospective review. However, data remain incomplete based on fragmented reporting, provider change, and loss of follow-up. New technologies are being developed to assist with this limitation, by joining health care systems' medical records, and tracking Medicare claims files. The future of health care will rely more heavily on these systems, and artificial intelligence to quickly pull relevant clinical and genomic data regarding particular diagnoses, as a means to personalize medicine...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213408/surgical-collaboratives-for-quality-improvement
#11
REVIEW
Amir A Ghaferi
How best to improve the surgical quality remains unknown. Historically, most efforts were either top down national policy efforts or local hospital/practice level efforts. This article reviews the limitations of these methods and how collaborative quality improvement a mix of local, regional, and national efforts is the most effective means of achieving sustainable, meaningful improvement in surgical care.
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213407/quality-measurement-and-pay-for-performance
#12
REVIEW
Jay S Lee, Hari Nathan
Recent debate has focused on which quality measures are appropriate for surgical oncology and how they should be implemented and incentivized. Current quality measures focus primarily on process measures (use of adjuvant therapy, pathology reporting) and patient-centered outcomes (health-related quality of life). Pay for performance programs impacting surgical oncology patients focus primarily on preventing postoperative complications, but are not specific to cancer surgery. Future pay for performance programs in surgical oncology will likely focus on incentivizing high-quality, low-cost cancer care by evaluating process measures, patient-centered measures, and costs of care specific to cancer surgery...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213406/repealing-the-affordable-care-act-and-implications-for-cancer-care
#13
REVIEW
Karan R Chhabra, Chad S Ellimoottil, Justin B Dimick
Calls to repeal the Affordable Care Act (ACA) have become increasingly frequent. Most attempts to repeal the ACA have targeted specific policies rather than the ACA as a whole. This article describes the specific policies under debate and the ramifications of repealing each of them. Specific attention is given to insurance coverage, individual premiums, and budgetary impact. Based on the literature regarding the ACA's impact to date, the impact of ACA repeal on Surgical oncology care is predicted.
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/30213405/implications-of-the-affordable-care-act-on-surgery-and-cancer-care
#14
REVIEW
Andrew P Loehrer, George J Chang
The Patient Protection and Affordable Care Act increased health insurance coverage to millions in the United States, transformed both the private and public insurance markets, and invested in care delivery changes in an attempt to increase the quality and value of health care. How these changes have translated to improved long-term oncologic outcomes, including for survivorship, remains to be seen. Newer models of payment and care delivery attempt to improve both short-term and long-term quality while better controlling cost trends...
October 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/29935693/current-management-of-peritoneal-surface-malignancy
#15
EDITORIAL
Edward A Levine
No abstract text is available yet for this article.
July 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/29935692/peritoneal-malignancies
#16
EDITORIAL
Timothy M Pawlik
No abstract text is available yet for this article.
July 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/29935691/palliative-management-of-advanced-peritoneal-carcinomatosis
#17
REVIEW
Laura A Lambert, Ryan J Hendrix
Despite advances in the management of peritoneal carcinomatosis, morbidity remains high with survival often measured in weeks to months. Patients are often subjected to symptoms and complications that impact quality of life. Much of the management revolves around palliation of symptoms and providing support and resources to address emotional and existential concerns. This article reviews surgical and nonsurgical palliative treatments for the symptoms and complications associated with advanced, incurable peritoneal carcinomatosis...
July 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/29935690/peritoneal-metastases-from-colorectal-cancer-treatment-principles-and-perspectives
#18
REVIEW
Diane Goéré, Isabelle Sourrouille, Maximiliano Gelli, Léonor Benhaim, Matthieu Faron, Charles Honoré
Peritoneal metastases are the third most common site of recurrence of colorectal cancer. Diagnosis is difficult and often made at an advanced stage even on imaging. Curative treatment relies on complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC), which dramatically improves survival in selected patients. Main prognostic factors are based on the extent of the peritoneal disease and the completeness of surgery. Therefore, identifying patients at high risk of developing peritoneal metastases with the aim of diagnosing and treating patients at an early stage appears crucial...
July 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/29935689/peritoneal-metastases-from-appendiceal-cancer
#19
REVIEW
Konstantinos I Votanopoulos, Perry Shen, Aleksander Skardal, Edward A Levine
The early symptoms of appendiceal cancer may mimic the clinical picture of appendicitis. Most patients are diagnosed incidentally during surgical exploration or late when peritoneal or systemic dissemination has already occurred, as colonoscopy rarely will diagnose an appendiceal cancer. Systemic/extraperitoneal metastases are distinctly unusual for appendiceal mucinous lesions.
July 2018: Surgical Oncology Clinics of North America
https://www.readbyqxmd.com/read/29935688/peritoneal-metastases-from-malignant-mesothelioma
#20
REVIEW
Claire Yue Li, H Richard Alexander
Diffuse malignant peritoneal mesothelioma (MPM) is a rare cancer that is ultimately fatal in almost all afflicted individuals. Morbidity and mortality from MPM is due to its propensity to progress locoregionally within the abdominal cavity. Patients with MPM most commonly present with nonspecific abdominal symptoms that usually lead to diagnosis when the condition is relatively advanced. MPM is considered a chemotherapy-resistant malignancy.
July 2018: Surgical Oncology Clinics of North America
journal
journal
31108
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"